Jyong Biotech Ltd. (MENS)

NASDAQ: MENS · Real-Time Price · USD

2.780

+0.290 (11.65%)

Apr 13, 2026, 3:54 PM EDT - Market open

Jyong Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 13, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	214	-	-	-	-	-
Enterprise Value	229.66	0	0	0	0	0
Debt / Equity Ratio	-1.54	-0.49	-0.48	-0.46	-0.49	-0.66
Debt / EBITDA Ratio	-18.32	-9.37	-6.25	-5.27	-5.17	-5.54
Debt / FCF Ratio	-	-5.00	-6.42	-4.43	-5.56	-11.01
Net Debt / Equity Ratio	-0.81	-0.49	-0.48	-0.45	-0.40	-0.45
Net Debt / EBITDA Ratio	-9.47	-9.32	-6.18	-4.97	-4.12	-3.73
Net Debt / FCF Ratio	-	-4.98	-6.35	-4.18	-4.43	-7.42
Quick Ratio	0.62	0.01	0.01	0.06	0.38	0.73
Current Ratio	0.62	0.02	0.13	0.19	0.42	1.08
Return on Equity (ROE)	9.98%	8.55%	13.81%	25.04%	19.74%	9.98%
Return on Assets (ROA)	-8.72%	-28.14%	-32.92%	-31.13%	-21.58%	-19.05%
Return on Invested Capital (ROIC)	-15.77%	-34.84%	-40.16%	-43.59%	-34.99%	-31.35%
Return on Capital Employed (ROCE)	-88.20%	34.93%	54.99%	552.54%	-47.12%	-34.62%
Buyback Yield / Dilution	-0.13%	0.00%	0.00%	0.00%	0.00%	-
Total Shareholder Return	-0.13%	0.00%	0.00%	0.00%	0.00%	-

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q